UncategorizedC2N files FDA submission for Alzheimer’s blood-test – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedMyrtelle releases interim data from gene therapy trial for Canavan disease – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedOmada Health rolls out Meal Map, AI tool to shift focus from calories to nutrient density – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedEmagene Life inks global partnership with IFM – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedChrysea and KaloCyte form exclusive alliance to advance biosynthetic blood solutions – Longevity.Technology Empower Meds / October 2, 2025
UncategorizedAerska emerges from stealth to combat brain diseases with RNAi Empower Meds / October 1, 2025
UncategorizedBiograph and Caristo begin US trial on AI heart disease detection – Longevity.Technology Empower Meds / October 1, 2025
UncategorizedAnavex publishes new data on oral blarcamesine in Alzheimer’s trial – Longevity.Technology Empower Meds / October 1, 2025
UncategorizedCognision and SOMNOmedics partner to provide sleep-biomarker tools in trials – Longevity.Technology Empower Meds / October 1, 2025
